uPAR: A modulator of VEGF-induced angiogenesis

Cell Adhesion and Migration

Volumn 7, Issue 1, 2013, Pages 23-26

  Uhrin, Pavel ^a   Breuss, Johannes M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Blood vessels; Endothelial cell migration; Integrin 5 1; uPAR; VEGF

Indexed keywords

UROKINASE RECEPTOR; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 5;

ANGIOGENESIS; ANIMAL CELL; CELL MIGRATION; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENDOCYTOSIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; NOTE; PROTEIN BINDING; PROTEIN INTERACTION;

EID: 84872179197     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22124     Document Type: Note

References (19)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9:653-60; PMID:12778163; http://dx.doi.org/10.1038/nm0603-653
2. Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci U S A 1985; 82: 4939-43; PMID:2991901; http://dx.doi.org/10.1073/ pnas.82.15.4939
3. Vassalli JD, Baccino D, Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 1985; 100:86-92; PMID:3880760; http://dx.doi.org/10.1083/jcb.100.1.86
4. Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, et al. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 1989; 108:1987-95; PMID:2523891; http://dx.doi.org/10.1083/jcb.108.5.1987
5. Prager GW, Breuss JM, Steurer S, Olcaydu D, Mihaly J, Brunner PM, et al. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor. Circ Res 2004; 94:1562-70; PMID: 15131009; http://dx.doi.org/10.1161/01.RES.0000131498.36194.6b
6. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994; 269:32380-8; PMID:7528215
7. Wei Y, Eble JA, Wang Z, Kreidberg JA, Chapman HA. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell 2001; 12:2975-86; PMID:11598185
8. Wei Y, Czekay RP, Robillard L, Kugler MC, Zhang F, Kim KK, et al. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol 2005; 168:501-11; PMID: 15684035; http://dx.doi.org/10.1083/jcb.200404112
9. Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999; 147:89-104; PMID: 10508858; http://dx.doi.org/10.1083/jcb.147.1.89
10. Schwarzenbacher M, Kaltenbrunner M, Brameshuber M, Hesch C, Paster W, Weghuber J, et al. Micropatterning for quantitative analysis of protein-protein interactions in living cells. Nat Methods 2008; 5:1053-60; PMID:18997782; http://dx.doi.org/10.1038/nmeth.1268
11. Chaurasia P, Aguirre-Ghiso JA, Liang OD, Gardsvoll H, Ploug M, Ossowski L. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J Biol Chem 2006; 281:14852-63; PMID:16547007; http://dx.doi.org/10.1074/jbc.M512311200
12. Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 2004; 103:955-62; PMID: 14525763; http://dx.doi.org/10.1182/blood-2003-07-2214
13. Mould AP, Garratt AN, Askari JA, Akiyama SK, Humphries MJ. Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit. FEBS Lett 1995; 363:118-22; PMID:7537221; http://dx.doi.org/10.1016/0014-5793(95)00301-O
14. Mazzieri R, D'Alessio S, Kenmoe RK, Ossowski L, Blasi F. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol Biol Cell 2006; 17:367-78; PMID:16267271; http://dx.doi.org/10. 1091/mbc.E05-07-0635
15. Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, Majdic O, et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995; 181:1381-90; PMID:7535337; http://dx.doi.org/10.1084/jem.181.4.1381
16. Kamisasanuki T, Tokushige S, Terasaki H, Khai NC, Wang Y, Sakamoto T, et al. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochem Biophys Res Commun 2011; 413:128-35; PMID:21875571; http://dx.doi.org/10.1016/j.bbrc.2011.08.068
17. Bhaskar V, Zhang D, Fox M, Seto P, Wong MH, Wales PE, et al. A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. J Transl Med 2007; 5: 61; PMID:18042290; http://dx.doi.org/10.1186/1479-5876-5-61
18. Bell-McGuinn KM, Matthews CM, Ho SN, Barve M, Gilbert L, Penson RT, et al. A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer. Gynecol Oncol 2011; 121:273-9; PMID: 21276608; http://dx.doi.org/10.1016/j.ygyno.2010.12.362
19. Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC, et al. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J Biol Chem 2007; 282:3929-39; PMID:17145753; http://dx.doi.org/10.1074/ jbc.M607989200